| # | Drug | Count |
|---|---|---|
| 0 | VORICONAZOLE | 236 |
| 1 | VORICONAZOLE INJECTION | 226 |
| 2 | PREDNISONE | 86 |
| 3 | TACROLIMUS | 77 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 74 |
| 5 | TACROLIMUS OINTMENT 0.1% | 74 |
| 6 | MYCOPHENOLATE MOFETIL | 65 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 65 |
| 8 | RITUXIMAB | 38 |
| 9 | ALENDRONATE SODIUM | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANIDULAFUNGIN | 18 | 0.0111 |
| 1 | VORICONAZOLE | 236 | 0.0077 |
| 2 | FLURANDRENOLIDE | 1 | 0.0030 |
| 3 | MICAFUNGIN SODIUM | 19 | 0.0029 |
| 4 | METEX | 1 | 0.0026 |
| 5 | BARICITINIB | 8 | 0.0026 |
| 6 | CORTISOL | 1 | 0.0025 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 15 | 0.0018 |
| 8 | TERBINAFINE HYDROCHLORIDE TABLET | 11 | 0.0015 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 4 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Azole Antifungal [EPC] | 239 |
| 1 | Corticosteroid [EPC] | 135 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 39 |
| 3 | Echinocandin Antifungal [EPC] | 31 |
| 4 | Alkylating Drug [EPC] | 27 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 19 |
| 6 | Polyene Antifungal [EPC] | 19 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 17 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 31 | 0.0038 |
| 1 | Azole Antifungal [EPC] | 239 | 0.0015 |
| 2 | Allylamine Antifungal [EPC] | 11 | 0.0015 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 19 | 0.0015 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 16 | 0.0007 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 14 | 0.0006 |
| 6 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 7 | Polyene Antifungal [EPC] | 19 | 0.0005 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 6 | 0.0005 |
| 9 | Penem Antibacterial [EPC] | 14 | 0.0004 |